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Abstract
The second Signal Processing and Monitoring in Labor workshop gathered researchers who utilize 
promising new research strategies and initiatives to tackle the challenges of intrapartum fetal 
monitoring. The workshop included a series of lectures and discussions focusing on: new 
algorithms and techniques for cardiotocogoraphy (CTG) and electrocardiogram acquisition and 
analyses; the results of a CTG evaluation challenge comparing state-of-the-art computerized 
methods and visual interpretation for the detection of arterial cord pH<7.05 at birth; the lack of 
consensus about the role of intrapartum acidemia in the etiology of fetal brain injury; the 
differences between methods for CTG analysis ‘mimicking’ expert clinicians and those derived 
from ‘data-driven’ analyses; a critical review of the results from two randomized controlled trials 
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testing the former in clinical practice; and relevant insights from modern physiology-based studies. 
We concluded that the automated algorithms performed comparably to each other and to clinical 
assessment of the CTG. However, the sensitivity and specificity urgently need to be improved 
(both computerized and visual assessment). Data-driven CTG evaluation requires further work 
with large multicenter datasets based on well-defined labor outcomes. And before first tests in the 
clinic, there are important lessons to be learnt from clinical trials that tested automated algorithms 
mimicking expert CTG interpretation. In addition, transabdominal fetal electrocardiogram 
monitoring provides reliable CTG traces and variability estimates; and fetal electrocardiogram 
waveform analysis is subject to promising new research. There is a clear need for close 
collaboration between computing and clinical experts. We believe that progress will be possible 
with multidisciplinary collaborative research.
Keywords
Health data; sensitivity; specificity; artificial intelligence; Cardiotocography; electronic fetal 
monitoring; intrapartum care; hypoxic-ischemic encephalopathy
INTRODUCTION
Continuous fetal heart rate (FHR) monitoring with cardiotocography (CTG) remains the 
mainstay of intrapartum fetal surveillance. Its intended goal is to prevent death or hypoxic-
ischemic encephalopathy, by identifying incipient hypoxia/ischemia in a previously healthy 
fetus, at a time when intervention can prevent or mitigate permanent injury. Its goal is not 
considered to be the identification of infection during labor or trauma related to the delivery. 
While pre-existing injury, anomaly or antenatal hypoxia may be suspected, on the basis of a 
deviant FHR pattern, it is unknown whether the injury associated with these factors can be 
mitigated or aggravated by obstetrical care during labor. Nonetheless, these factors modulate 
the risk of neural injury and can influence the FHR trace, along with the timing and urgency 
of delivery. In addition, hypoxic-ischemic encephalopathy does not represent either a single 
clinical picture or pathogenesis. Injury evolves over hours and its physiological 
manifestations (in FHR changes or other signs) are not confined to a single short period of 
time1. On the other hand, some injurious events develop precipitously and show non-
standard FHR and/or neuroradiological patterns2. These occurrences may not be 
preventable, but emergency operative delivery may still be warranted. For example, in order 
to start hypothermia treatment promptly; or in order to prevent exacerbating the injury by 
allowing the labor to continue.
Evidence has been available for nearly half a century that FHR abnormalities are often not 
related to fetal acidosis3,4. As a result, the rate of unnecessary operative deliveries is high5,6 
with adverse implications for this and/or subsequent pregnancies. Furthermore, even experts 
disagree with each other when interpreting the intrapartum FHR (for example, Chauhan et 
al7). Clinical guidelines that focus on the CTG morphology in isolation, encourage clinicians 
to conclude that every FHR pattern has a single and straightforward correct interpretation8. 
In reality, often complex interactions between multiple clinical factors need to be taken in to 
account.
GEORGIEVA et al. Page 2
Acta Obstet Gynecol Scand. Author manuscript; available in PMC 2020 September 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
Recent randomized clinical trials (RCT) for novel intrapartum monitoring technologies have 
largely failed to show improvement in neonatal outcomes when compared to current visual-
based CTG monitoring9–11. But large clinical retrospective studies of intrapartum computer-
aided FHR interpretation (mimicking clinical experts) in conjunction with other 
technologies, are more optimistic12,13 (38,466 and 78,456 births in the respective studies). 
With no other surveillance modalities on the horizon and the raise of artificial intelligence 
and data analytics for healthcare, now is the time to create opportunities for 
multidisciplinary joint efforts, pushing new boundaries in an attempt to move forward. For 
example, FHR algorithms that harness the complex information from large clinical datasets 
are under development and have never been tested in the clinic: Georgieva et al 2017, using 
data from 22,000 births demonstrated that a very simple data-driven system compares 
favorably to clinical CTG evaluation in prediction of several types of poor neonatal outcome. 
With larger datasets and more sophisticated methods, we expect that such systems would 
evolve to play an invaluable role in the future of intrapartum FHR analysis. Further research 
is needed to test this hypothesis.
But these algorithms cannot be developed in a vacuum. Indeed, a number of related factors 
require consideration. Obstetrical decisions relate to two independent organisms where 
efforts to benefit one may be harmful to the other; the preventability of injury; the feasibility 
of safe vaginal delivery; the trajectory of deterioration; the need to defend against allegations 
of malpractice; the need for urgent delivery and the maintenance of a reasonable frequency 
of cesarean delivery; and more. But there is a clear need for reliable and objective 
technologies to monitor and help clinicians identify the fetus at risk during labor.
This gives the motivation for the bi-annual Workshop on Signal Processing and Monitoring 
in Labor (SPaM), where a broad range of multidisciplinary new research strategies and 
initiatives are considered. The aims of the SPaM Workshop are to provide ”a truly 
multidisciplinary forum and spirit and common language for clinicians, physiologists and 
signal processing researchers” (Workshop webpage: https://www.wrh.ox.ac.uk/research/
spam-in-labour). Registration through the website of the workshop is open to everybody 
willing to attend. Opportunity is given to anyone willing to give a talk on a relevant subject 
with ample time for discussions and questions. There have been no abstract submissions or 
proceedings so far. We gathered participants from Europe, USA, Canada, and New Zealand, 
including experts from obstetrics, engineering, computer science; machine learning; 
physiology, physics and epidemiology. There were representatives from the producers of 
fetal monitors (Phillips, GE/Monica Healthcare, Huntleigh Healthcare, Nemo Healthcare 
and Laerdal Medical) and medical or engineering students.
This paper is designed to provide a current review of computer-based methods for 
continuous fetal monitoring and relevant clinical trials; set a benchmark of state-of-the-art 
performance of such methods on multicentre data; critically examine the most important 
obstacles and controversies impeding progress; sign-post the reader to the newest relevant 
research; and outline the most promising future directions for research.
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STRUCTURE AND MAIN TOPICS OF THE WORKSHOP
In this paper, we review the main themes and ideas of the meeting, rather than individual 
presentations, which are available through the workshop webpagei (including video 
recordings of the talks). The workshop discussions gravitated around the following main 
topics:
1. The concepts of computerized FHR monitoring: ‘mimicking’ clinicians versus 
‘data-driven’ interpretation;
2. The SPaM’17 CTG challenge: evaluation of computerized methods with respect 
to cord acidemia at birth and visual clinical interpretation;
3. Defining the endpoint(s) of intrapartum monitoring: the ‘good’ and ‘bad’ labor 
outcomes;
4. Signal processing methods for data-driven computerized CTG;
5. Visual-aid computerized CTG: lessons from RCTs;
6. Trans-abdominal fetal ECG monitoring;
7. Fetal physiology in the age of big data;
8. Beyond FHR: emerging technologies and adoption challenges;
9. Bringing new monitoring modalities to the market.
THEMES HIGHLIGHTED DURING THE WORKSHOP
1. The concepts of computerized fetal heart rate monitoring: ‘mimicking’ clinicians 
versus ‘data-driven’ interpretation
Two approaches to computerized CTG analysis have been developed in the past: (a) 
systematic visual assessment to identify classic CTG features such as baseline, variability, 
decelerations/accelerations, contractions, with alerts based on clinical guidelines; (b) data-
driven methods that use routinely collected CTG and fetal health data to investigate signal 
processing-based metrics and/or interpretation methods that best relate to measures of fetal 
wellbeing and labor outcome. The data-driven concept is based on analyzing a very large 
number of records (at the very least a few thousands, but as the next decade of ‘big data’ 
unfolds, even millions of CTGs); with the capacity of learning to recognize rare events, such 
as hypoxic-ischemic encephalopathy. Below in theme 4, these emerging methods are 
reviewed in more detail and the reader is signposted to the relevant literature.
The visual-aid methods, which have been evaluated in two RCTs discussed below, have the 
potential to reduce the lack of objectivity, limited availability or training of clinical staff, and 
human error/fatigue. In contrast, with larger FHR/CTG datasets and increasing computing 
power, researchers can now focus on data-driven methods (reviewed below). Data-driven 
approaches tackle the same issues as the visual-aid approaches but also directly aim to 
improve the detection of infants at high risk for intrapartum compromise, learning from vast 
amounts of data. Such methods are still undergoing development and none have been tested 
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in clinical studies yet. Therefore, we underline the fundamental difference between the two 
computer-based approaches to FHR evaluation.
2. The SPaM’17 CTG challenge: evaluation of computerized methods with respect to cord 
acidemia at birth and visual clinical interpretation
A multicenter dataset was assembled before the workshop, and is now available at the 
Workshop webpagei. This SPaM’17 database comprises 300 labors collected from three 
participating centers (Lyon, France; Brno, Czech Republic; and Oxford, UK). Each center 
provided 100 cases: 80 with arterial cord pH in with values within 7.25–7.30 and 20 with 
arterial cord pH<7.05. Only cases with validated cord gases were included (arterial pH < 
venous pH – 0.02). The goal was to “evaluate state-of-the-art algorithms for prediction of 
low umbilical artery pH at birth from intrapartum CTG recordings”. Included were only 
singleton pregnancies of more than 36 weeks gestation. Excluded were small for gestational 
age babies and those with congenital abnormalities. Selected were only CTGs longer than 60 
minutes, with less than 15% signal loss and ending within ten minutes of birth. All CTGs 
were acquired as part of standard clinical practice at the respective units, with standard CTG 
monitors and the FHR was only available to the researchers uniformly sampled at 4Hz, as 
per standard manufacturing. Teams were allowed up to five submissions and were informed 
about their ‘score’, calculated as the square root of Sensitivity (Se) multiplied by Specificity 
(Sp). Se and Sp were also reported and discussed at the workshop.
Overall, eight teams participated and had comparable performance. Two teams used the 
SPaM’17 dataset as a ‘training’ dataset, informing their algorithms development according 
to the obtained score and two teams used the dataset to test new applications of algorithms, 
still under development (no relevant publications). The remaining four teams used 
established algorithms for CTG analysis that had been developed and tested prior to the 
challenge: SisPorto 4.0 incorporating the International Federation of Gynecology and 
Obstetrics (FIGO) clinical guidelines14; Phase Rectified Signal Averaging (OxSys 1.0), 
tuned using over 7,000 CTGs from Oxford5,15; Sparse Support Vector Machines trained 
using over 1800 CTGs from Lyon16,17; Auto mutual information applied only to the last 
30min of first stage labor, and was tuned using over 900 CTGs from Lyon18. Summary 
statistics of the Se and Sp values for the latter four methods are shown in Table 1. There was 
a substantial variance of performance of all algorithms with respect to where the data came 
from (Oxford, Brno or Lyon), underlying the importance of multicenter datasets.
Twenty selected CTGs from the 300 were also evaluated by five clinicians, blinded to 
outcome. Selected were the CTGs for which the automated methods had the highest 
disagreement between themselves and/or majority did not predict correctly the labor 
outcome. Ten of the 20 had arterial cord pH < 7.05. The obstetricians were asked to identify 
the cases which are likely to have arterial cord pH < 7.05 and/or require early operative 
delivery. No other information, but the CTG was provided. The images of CTGs were 
provided in both EU standard (1cm/min) and US standard (3cm/min), one US-based and 
four EU-based doctors responded to the challenge. Four of the clinicians are currently 
practicing obstetricians consultants in Europe (UK, Portugal and the Czech Republic) and 
one is US-based. They all have both clinical and academic interest in CTG interpretation.
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The main results from the visual evaluation for the prediction of arterial cord pH < 7.05 
could be summarized as follows:
• All five clinicians agreed with each other in five out of the 20 CTGs; only four 
clinicians agreed with each other for nine out of 20; and only three clinicians 
were in agreement for the remaining six CTGs.
• Majority vote (MV) of the automated methods agreed with MV of the clinicians 
in 85% (17 out of 20) of the selected CTGs. For the remaining three cases, the 
clinical MV correctly predicted the outcome whereas the automated methods’ 
MV did not.
• MV(algorithms) and MV(clinicians) agreed but did not correctly predict the 
labor outcome in six of the 20 cases: four were false negatives and two were false 
positives.
The controversial nature of CTG evaluation was evident not only in the results of the 
challenge but during their discussion at the workshop’s dedicated session. Firstly, defining 
labor outcome by cord gas analyses was deemed unsuitable by some of the participants (as 
discussed in detail below in Theme 3). Secondly, the clinicians were visibly challenged to 
discuss their CTG interpretation in this kind of competitive manner, especially with no 
clinical context provided (but this was required in order to compare fairly to automated 
methods). Moreover, many of the active clinical participants in the workshop did not submit 
formally their evaluations.
We concluded that, generally speaking, the automated algorithms perform comparably to 
each other and to clinical assessment of the CTG (with no clinical context). It is important 
that data from multiple hospitals is used. Most importantly, Se and Sp urgently need to be 
increased by future work (both computerized and visual assessment). But we note that the 
optimal Se and Sp that (in theory or practice) could be achieved with the best possible CTG 
interpretation, remain unknown and heavily depend on the way fetal compromise is defined 
(discussed in the next section).
3. Defining the endpoint(s) of intrapartum monitoring: the ‘good’ and ‘bad’ labor 
outcomes
Without defining and quantifying the outcomes of labor that we want to prevent, we cannot 
assess whether one method for monitoring is better than another, and ultimately cannot 
progress. The issue of how to define the relevant outcomes has been one of the most 
important and debated problems during the SPaM workshops. There remains no clarity or 
consensus about the goal of intrapartum CTG monitoring, in particular, the role of 
intrapartum acidemia in the etiology of fetal brain injury which remains one of the biggest 
challenges in data-driven CTG analysis. We summarize below the discussions relating to this 
issue and provide relevant references to sign-post the reader.
About two thirds of speakers at the workshop used a single cord gas parameter in their 
research (pH or base deficit). Fetal acidosis at birth is a risk factor for clinically important 
neurological outcomes such as convulsions and neonatal encephalopathy, but a large 
proportion of newborns with very low pH / high base deficit values are clinically well and do 
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not require special neonatal care6,19. The remaining third of researchers used hypoxic-
ischemic encephalopathy (HIE) or composite outcomes as endpoints of intrapartum CTG. 
The adopted definition of HIE was confounded by including acidemia as a requirement for 
HIE (discussions of the ways to define HIE can be found in Kurinczuk et al.20, ACOG 
201421, Leviton et al22 and the references therein). Importantly, the acidemia prerequisite for 
HIE diagnosis, leaves out of the analysis the newborn with brain injury, but normal cord 
gases at birth. Highlighted was the importance of complex intrapartum factors such as 
maternal fever, infection, meconium, growth restriction, pre-existing injury. These and/or 
other risk factors may perturb fetal cerebral function and FHR patterns in the absence of 
acidemia. Further understanding of these and other factors, their effect on intrapartum FHR 
and how they modulate the utility of current/future biomarkers of hypoxic-ischemic injury is 
urgently needed. If the importance of cord blood gas analysis is to be reduced, what indices 
of labor outcome can be objectively measured to assess the impact of improved CTG 
analysis? And, from the point of view of data-driven methods, there may well be the need 
for different algorithms to detect these heterogeneous pathophysiological mechanisms, 
which may manifest themselves differently in the FHR pattern. In other words, we need to 
understand the different pathways to fetal injury and, for each of these ‘models’ of injury 
evolution, identify the appropriate role of various CTG patterns.
These complexities underline the clear need for close collaboration between computing and 
clinical experts, and the need for research/time before tangible results could be achieved.
4. Signal processing methods for data-driven computerized CTG
Figure 1 provides a general overview for the concepts in applying computers for signal 
processing and machine learning for data-driven computerized CTG. We note that the 
principles illustrated here are by no means unique to CTG, but they underline most 
situations where we teach the computers to recognize and analyze complex real-world 
information, i.e. developing artificial intelligence for decision support. The key concepts are: 
availability of data to learn from (training and testing datasets); signal feature extraction and 
selection (finding the most important information in the data); machine learning to classify 
the CTG signals (use that information to achieve as good as possible accuracy, i.e. develop 
mathematically optimal methods); and the relatively new and quickly developing field of 
deep learning where feature extraction, selection and machine learning are (in a way) fully 
automated and optimized by a super-computer.
(1) Feature extraction—Clinical guidelines for CTG analysis are derived from FIGO or 
similar sources23. They focus on the three main FHR characteristics, namely, baseline rate 
(level, trend), decelerations/accelerations (frequency, shape, depth, duration), and variability 
(long- or short-term). It is well appreciated that visual assessment of these criteria suffers 
from significant intra- and inter-observer variability24 and leads to unnecessary operative 
deliveries25.
Besides the automated analysis of temporal patterns inspired by FIGO criteria, FHR 
temporal dynamics have been further assessed by spectrum estimation; i.e., the repartition of 
energy as a function of frequency, in the range 0.04 to 2Hz, with the calculation of high 
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frequency (HF) and low frequency (LF) energies or LF/HF ratio, quantifying a putative 
sympathovagal balance in fetuses26. Further, more advanced statistical signal processing 
tools have been used, probing either nonstationarities (time-frequency), scale-free dynamics 
(wavelets, fractal) and/or nonlinear mechanisms and hence dependencies beyond the mere 
correlation (bispectrum, information theoretic measures, entropy rates, multifractal analysis, 
scattering transforms, conditional statistics as in the Phase Rectified Signal Analysis 
method15,16,18,27–30). These result in many different FHR features/characteristics. Yet, it is 
generally well accepted that, on their own, FHR changes are not enough for use in clinical 
practice and a recent review re-emphasized the need for the wider clinical picture in the 
interpretation and management of FHR patterns during labor31. Therefore, Georgieva et al.5 
presented a basic system prototype to assess the CTG, based mainly on one feature (the 
Phase Rectified Signal Averaging), but adjusted the analysis to clinical risk factors and 
achieved performance comparable to that of clinical practice (applied to the CTGs of over 
22,000 births). Georgieva et al.5 demonstrated that such ‘hybrid’ approaches (that combine 
CTG metrics with other risk factors) are likely to lead to better performance of the 
classifiers, but require reliable documented clinical data (e.g. that of maternal 
comorbidities).
(2) Feature selection and classification (machine learning)—Machine learning 
for classification into normal or abnormal has included several methods for automated 
‘classification’, such as Bayesian32, Support Vector Machines33,34, Random Forest, and 
Artificial Neural Networks35, and often involved almost all proposed features. However, 
different features may often provide redundant/correlated information. Whereas, joining 
feature selection and optimal classification into one step, has demonstrated that a few well-
chosen features are as efficient as rules involving many features16,17,34. In addition, it can be 
shown that FHR interpretation rules for the first and active-pushing stages of labor may need 
to be different16,17.
(3) Deep Learning approaches—Finally, FHR analysis would benefit from the wider 
availability of large, documented and shared databases that permit robust evaluation of 
detection/performance of different machine learning methods. In particular, such data could 
be used with approaches based on ‘deep learning’ strategies36,37. These are powerful, next 
generation artificial intelligence approaches, where the computers independently seek what 
is important in the data and do not rely on human-derived features/characteristics. For 
example, preliminary work by Petrozziello et al. 201836 demonstrates that convolutional 
neural networks, trained with the data from 30,000 labors at term, have promising 
performance; and their accuracy and robustness increase with the size of the training 
dataset36.
In summary, data-driven FHR interpretation needs further research and will benefit from 
larger datasets based on well-defined labor outcomes which include clinically relevant risk 
factors and co-morbidities. With a longer-term view and the introduction of full electronic 
patient records in the developed countries, we anticipate that CTG databases available for 
research could grow to hundreds of thousands of cases, and even millions. In the UK alone, 
over 300,000 labors at term are monitored with CTG each year.
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5. Visual-aid computerized CTG: lessons from RCTs—Two systems comparing 
computerized CTG analysis to visual assessment were recently evaluated in multicenter 
randomized trials in the United Kingdom. The FM-Alert trial21 assessed the Omniview-
SisPorto® 3.5 system36 in 7,730 pregnant women at term. The system analyses both CTG 
and ECG signals (ST-analysis) and provides real-time alerts when features are suggestive of 
fetal hypoxia/acidosis. There was no overall reduction in the rates of metabolic acidosis (16 
(0.40%) vs 22 (0.58%), RR 0.69 [0.36–1.31]) nor in obstetric interventions; in higher risk 
groups of women, with complications preceding or arising de novo during pregnancy, it may 
confer benefit. There was a lower than expected rate of newborn metabolic acidosis – the 
primary outcome - in both arms of the trial.
The INFANT Trial11 evaluated the INFANT (K2 Medical Systems) – decision-support 
software38,39. In this unmasked RCT, 47,062 pregnant women were randomly assigned to 
the computerized CTG group or the standard clinical care group. No differences were found 
in the incidence of poor neonatal outcome (a composite outcome for intrapartum stillbirth or, 
early neonatal death, or neonatal encephalopathy, neonatal unit admission within 24h for ≥ 
48h with evidence of feeding difficulties, respiratory illness, or encephalopathy with 
evidence of compromise at birth) between the groups (172 (0·7%) vs 171 (0·7%), adjusted 
RR 1.01, 95% CI 0.82–1.25)). At two years of age, no significant differences were noted in 
developmental scores.
Neither trial found evidence for benefit from using the computerized systems to improve 
neonatal outcomes. Both encountered the same issue of a lower than expected incidence of 
the primary adverse outcome. This may have been caused by staff learning from exposure to 
the decision-support arm of the trial, resulting in improved outcomes in the control arm 
(Hawthorne effect). Other methodological issues including multiple comparisons, strengths 
of findings and plausibility, and the evaluation of the significant findings in secondary 
outcomes were discussed at a dedicated workshop session with the following conclusions:
1. CTG in labor is a screening tool, not a therapeutic device or drug. It is unlikely to 
improve outcomes unless it is followed by effective, necessary interventions. 
This depends on many factors including clinician performance, resources and 
training. Neither trial defined clinical actions in response to the alerts. It is also 
not clear if alerts were ignored: in the INFANT Trial, the median time from 
identification of the last “red” alert to birth, was 13–279 min across different 
units, suggesting disparate approaches to severe CTG abnormalities. A 
standardized, specified list of actions (such as delivery or not; discontinuation of 
oxytocin infusion) in response to well-defined CTG and uterine activity patterns, 
combined with post-hoc monitoring of compliance, could be considered in future 
trials.
2. The Hawthorne Effect. If both INFANT and FM-Alert improved staff FHR 
interpretation skills, these benefits may be extended to the care of women in the 
control arms thereby contaminating them. This could be prevented in future trials 
by using a cluster randomized methodology.
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3. Future RCTs should have a period of pre-randomization benchmarking of 
outcome data. In these trials there was a missed opportunity to evaluate outcome 
data from low risk women who did not have continuous monitoring and from 
high-risk women who had continuous monitoring with standard care only40.
4. The studies reported a very low incidence of poor perinatal outcomes, including 
stillbirths, perinatal brain damage or neonatal death, compared to rates found in 
UK Obstetric Units41. Similar findings have been reported by others42,43 
meaning studies may be underpowered to detect the predefined differences. It 
appears that women participating in studies evaluating intrapartum fetal 
monitoring have better perinatal outcomes; this suggests that there is an urgent 
need to improve knowledge and training regarding appropriate responses to CTG 
abnormalities in general.
5. Do the specific algorithms used by the evaluated systems simply not work? Both 
systems identified fetal heart-rate abnormalities; however, the alerts did not take 
into account other data from labor such as its progress, maternal fever, 
chorioamnionitis or the presence of meconium. More importantly, algorithms 
mimicking clinicians cannot be expected to work better than the best clinical 
expert. This is unlike data-driven algorithms that have the potential to learn from 
vast amounts of past data. Unfortunately, there was no provision to store and 
make data available to research beyond the RCT in INFANT. However, the team 
behind the FM-Alert trial are putting efforts to obtain and use the data from their 
trial for further research.
In summary, we should consider the discussed complexities when designing intrapartum 
fetal monitoring RCTs. Large and well conducted clinical observational studies 12,13 may be 
a technical and financially attractive alternative to produce good scientific evidence for new 
technologies in the field.
6. Trans-abdominal fetal electrocardiogram monitoring
The fetal electrocardiogram (ECG) can be measured non-invasively by positioning 
electrodes on the abdomen of a pregnant woman44–46. The key challenge is to suppress 
interference from the maternal ECG. Recent studies confirm that this challenge can be 
successfully addressed by advanced signal processing methods47,48. Assessment of the fetal 
ECG has the potential to provide accurate information on FHR variability and enable ECG 
morphology analysis. Especially via computerized analysis5,49–51, fetal ECG may be able to 
provide risk assessment on fetal compromise better than possible when using FHR 
variability obtained via Doppler ultrasound52.
In particular, CTG is bound by a lower temporal precision in identifying beat-to-beat 
information (fetal heartbeat information derived with ultrasound or fetal scalp electrode by 
standard monitors at a uniform frequency of ~4Hz). True beat-to-beat data is needed for 
some of the derivative estimates of the FHR variability with a potential to improve the 
prediction of neonatal outcomes53. Its utility remains to be investigated in the future with the 
advance of transabdominal technologies and appropriate data collection. In addition, the 
question remains whether the within monitor internal pre-processing of the data, which may 
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vary from vendor to vendor, has any impact on automated FHR variability estimation. But 
technological advancement in isolation may not solve the utility of FHR variability and we 
need to understand in what situations it is useful, given the complex nature of FHR 
variability and its relation to fetal compromise (discussed in the next section). Also, any risk 
assessment could be complemented with further screening for metabolic acidosis54,55 or 
even congenital heart disease56.
To complement analysis of FHR variability, morphological analysis of the fetal ECG could 
potentially play a crucial role. This remains to be investigated, and we underline the need to 
collect relevant data that can be used to address this question. Furthermore, because fetal 
position affects ECG morphology analysis and the positioning of abdominal electrodes is 
unknown with respect to fetal orientation (i.e. fetal heart axis), multi-lead ECG recordings 
are necessary to correct for fetal orientation. Multiple leads allow correction for inter-patient 
variations in, for example, the fetal electrical heart axis, which may be vital for the detection 
of fetal metabolic acidosis44.
Finally, transabdominal electrophysiological monitoring can also provide information on 
uterine activity during labor. Conventional CTG interpretation considers variations in FHR 
in presence/absence of uterine contractions and recent studies have shown that also 
computerized CTG interpretation benefits from reliable information on uterine activity36,37. 
The current standard for non-invasive assessment of uterine activity relies on the 
tocodynamometer, a strain gauge held in place on the abdomen by a belt. This 
tocodynamometer typically provides low-quality signals57 and its performance degrades for 
higher body-mass-index (BMI) of the laboring women58. With transabdominal monitoring, 
information on uterine activity can be calculated that has been shown to have good 
correlation with intra-uterine pressure59,60. Moreover, the quality of the transabdominal 
uterine signals is not affected by BMI61.
Compared to standard fetal monitoring technologies, transabdominal fetal ECG monitoring 
is completely noninvasive and entirely avoids the issue of transducer re-positioning58.
To sum up, transabdominal fetal ECG can already estimate FHR variability more accurately 
than CTG. It is truly non-invasive and does not expose the fetus to ultrasound waves. The 
capability for morphological analysis of fetal ECG waveform is advancing, but there needs 
to be more research in the interpretation of these waveforms, with or without associated 
FHR analysis.
7. Fetal physiology in the era of big data
The original introduction of CTG was tightly linked to the underlying physiology and indeed 
many of the pioneers of CTG undertook seminal physiological studies62–64, which continue 
to guide the way clinicians, physiologists and now engineers and computer scientists 
approach CTG interpretation. One of the founding principles of CTG interpretation was that 
decelerations have multiple etiologies some of which are benign. Distinguishing these 
‘benign’ early decelerations from ‘pathological’ late decelerations and the sometimes-
pathological variable decelerations was therefore important62,64,65. Another key principle 
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was that suppressed FHR variability appeared to be the most consistent predictor of neonatal 
acidemia63.
This original physiology-driven approach is now being refined by data-driven approaches. 
Intriguingly, the findings that have emerged to date from large retrospective and prospective 
clinical studies4,66 are not consistent with some of the guiding principles of CTG. For 
example, the majority of acidemic fetuses do not show suppressed FHR variability, and can 
even show increased FHR variability4,15,67–69. Moreover, the morphological or timing-based 
classification of decelerations is not associated with acidemia (cord pH < 7.1), but in 
contrast the assessment of the depth and duration of all decelerations via metrics such as 
‘total deceleration area’ or ‘deceleration capacity’ is associated with acidemia4,15,34,67.
These modern clinical findings are not minor tweaks to CTG interpretation, but illustrate 
that the physiology underlying CTG is not what we were taught to expect. This is paralleled 
by a much deeper understanding of fetal physiology, through well-designed animal 
studies70. Many of these animal studies involve highly structured sequences of repeated 
umbilical cord occlusion modelling the intermittent nature of hypoxemia associated with 
uterine contractions71, but are in no way designed to truly reflect the complex and dynamic 
nature of human labor. Nonetheless, they allow the physiological mechanisms underlying 
specific features of the FHR trace to be investigated. With these caveats in mind, it is 
striking that the lessons learned from these animal studies have converged with the lessons 
from recent clinical studies. For example, animal studies reveal that the regulation of FHR 
variability during labor is complex and cannot be reduced to a binary system in which high 
equals good and low equals bad71,72, paralleling the inconsistent predictive value of FHR 
variability in clinical studies4,15,67–69. Modern understanding of the fetal peripheral 
chemoreflex (the response to hypoxemia) and the fetal baroreflex also concludes that the 
peripheral chemoreflex is the most likely mediator of the vast majority of intrapartum 
decelerations71, while the common belief that many decelerations are explained by 
baroreflex activation is in fact false (discussed in detail in 71). The clinical relevance of this 
physiological understanding is that the assessment of the depth and duration of all 
decelerations should provide a broad measure of the total burden of fetal hypoxemia, while 
the timing of decelerations is a red herring that does not reflect the etiology mediating 
decelerations in the way it was once thought. Indeed, recent clinical studies have highlighted 
that metrics consistent with these concepts (total deceleration area and deceleration capacity) 
are the most predictive metrics identified to date of cord acidemia and outperform traditional 
timing-based assessment of decelerations4,15,34,67.
It is now apparent that we need to be cautious of preconceived ideas about which FHR 
patterns are associated with fetal wellbeing. A data-driven approach therefore has an 
important role in the future refinement of CTG and represents the best opportunity to date to 
retest, reconfirm or refute long-held beliefs about the utility, and even the physiological 
meaning of FHR patterns.
8. Beyond fetal heart rate: emerging technologies and adoption challenges
Whilst we acknowledge the importance of capturing information on reduction of cerebral 
blood flow or fetal infection/inflammation, which are recognized precursors of fetal brain 
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injury, we lack the clinical tools to make these observations reliably during labor, directly or 
indirectly. Preclinical studies however do indicate that inflammatory indices may be 
developed from heart rate variability derived from the high-precision abdominal ECG that 
could potentially serve as real-time non-invasive infection biomarker73–75. The clinical 
adoption challenge to validate these results in prospective studies lies in the currently limited 
availability and use of the fetal ECG devices (the main motivation to using transabdominal 
fetal ECG devices remains its superiority for monitoring obese mothers, rather than potential 
signal-analytical benefits of higher quality fetal ECG signal). The technology is currently 
available only in few delivery centers with a limited number of devices.
Secondly, there is a resurgence of interest in using fetal EEG monitoring during labor76–78, 
to make neurological assessment of the fetus. This approach continues initiatives that began 
more than 40 years ago79,80. Fetal EEG monitoring can be performed using the routine fetal 
scalp electrode or specially designed electrodes78,81. It represents a clinically testable 
modality for increasing the accuracy of early detection of fetal acidemia82 or cerebral blood 
flow79,80. In particular, there appears to be an early response in the fetal EEG to repetitive 
FHR decelerations accompanied by pathological hypotensive blood pressure responses 
induced by brief umbilical cord occlusions83 which warrants further investigations.
Finally, to be taken up by practitioners, and to produce a change in health outcomes, the 
right idea has to arrive at the right time and be met by a technology that can implement 
it52,84,85. Proving the clinical utility of transabdominal ECG or fetal EEG is a prerequisite to 
their wider adoption. Although the technologies seem to have arrived, a paradigm shift will 
likely be required for practitioners to embrace them.
9. Bringing new monitoring modalities to the market
Innovations in fetal monitoring and surveillance are difficult to implement into clinical 
practice for three main reasons. Firstly, maternity departments spend most of their money on 
personnel rather than investments in technology or medical devices. With budgets for 
departments decreasing in most of the world, such investment in technology is even more 
difficult nowadays. Secondly, innovations are hindered by a paradox in the reimbursement 
system: in countries where hospitals have a revenue per admission or treatment, the net 
revenue of the maternity department may decrease due to innovations that help reduce the 
need-to-treat. At the same time, global costs of healthcare would be reduced by successful 
fetal monitoring innovations, but the cost savings might be made elsewhere in the system – 
sometimes close to maternity wards, e.g. in neonatology departments; or sometimes much 
further away, e.g. reduced costs related to care for those with neurological or educational 
problems. Especially in the latter case, maternity wards are not strongly inclined to invest 
their already limited budget in innovative technology.
Moreover, to allow reimbursement for new technology, insurance companies and national 
healthcare systems need to see evidence that cost savings can be made. But without such 
reimbursement for the new technology, hospitals will often not introduce it in their maternity 
wards, because of the abovementioned budgeting considerations. This makes it difficult to 
prove the technology’s cost efficiency or its benefits for the women and newborns. This 
chicken-and-egg problem can be resolved by clinical trials, but these are subject to multiple 
GEORGIEVA et al. Page 13
Acta Obstet Gynecol Scand. Author manuscript; available in PMC 2020 September 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
drawbacks, some of them specific to the field of fetal monitoring, discussed in detail in 
Theme 5 above.
CONCLUSION
The 2nd SPaM Workshop provided a unique and stimulating research forum for academics, 
clinicians, and industry. We concluded that modern automated algorithms for CTG 
evaluation perform comparably to each other and to clinical assessment of the CTG (with no 
clinical context), but the sensitivity and specificity urgently need to be improved. 
Furthermore, there remains a lack of clarity or consensus about the goal of intrapartum CTG 
monitoring, in particular, the role of intrapartum acidemia in the etiology of fetal brain 
injury. From the point of view of developing data-based methodologies, a definition of 
‘good’ and ‘bad’ outcomes of labor remains crucial.
We envision that technological progress will arrive in three ways: (1) through better quality 
and more reliable acquisition of FHR signals; (2) through novel techniques to acquire 
additional information about the fetus continuously during labor; (3) but mainly through 
harnessing the power of clinical data at large scale, employing computers to learn and help 
us understand the relations between FHR, clinical context and neonatal outcomes.
We firmly believe that the computing revolution can meaningfully assist in the development 
of a long overdue, reliable, continuous means for monitoring fetal health during labor and 
thus, ultimately, allow the prevention of intrapartum fetal injury where possible. Progress 
will only be possible with multidisciplinary collaborative research; the availability of large 
multicenter datasets; funding for research; and carefully designed clinical tests of the new 
technologies, learning from past mistakes.
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Figure 1. 
Overview of the concepts for data-driven CTG analysis.
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Table 1.
SPaM’17 CTG challenge: performance in detecting arterial cord pH<7.05 of the four established methods: 
SisPorto 4.014; OxSys 1.05,15; Sparse Support Vector Machines16,17; Auto mutual information18. Oxford, 
Lyon and Brno provided 100 CTGs each: 20 with arterial cord pH<7.05 and 80 with pH>7.25. The number of 
true positives and true negatives can then be calculated by dividing the numbers in the Table by five.
Median (Min-Max) Sensitivity (%) Specificity (%)
Oxford data subset 62.5 (55–65) 74 (64–84)
Lyon data subset 77.5 (75–95) 76 (60–78)
Brno data subset 55 (45–65) 71.5 (70–72)
All data 65 (60–73) 73 (70–74)
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